Peapack-Gladstone Financial Corp’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.39M | Buy |
10,991
+917
| +9% | +$121K | 0.02% | 382 |
|
|
2026
Q1 | $1.4M | Buy |
10,074
+891
| +10% | +$125K | 0.02% | 371 |
|
|
2025
Q4 | $1.13M | Buy |
9,183
+2,865
| +45% | +$348K | 0.01% | 391 |
|
|
2025
Q3 | $701K | Sell |
6,318
-2,241
| -26% | -$255K | 0.01% | 447 |
|
|
2025
Q2 | $949K | Sell |
8,559
-1,027
| -11% | -$109K | 0.01% | 399 |
|
|
2025
Q1 | $1.07M | Buy |
9,586
+69
| +0.7% | +$7.12K | 0.02% | 391 |
|
|
2024
Q4 | $878K | Sell |
9,517
-438
| -4% | -$39.4K | 0.01% | 403 |
|
|
2024
Q3 | $834K | Sell |
9,955
-1,037
| -9% | -$79.1K | 0.01% | 415 |
|
|
2024
Q2 | $754K | Sell |
10,992
-2,247
| -17% | -$150K | 0.01% | 424 |
|
|
2024
Q1 | $970K | Sell |
13,239
-9,793
| -43% | -$753K | 0.02% | 402 |
|
|
2023
Q4 | $1.86M | Buy |
23,032
+1,133
| +5% | +$88.2K | 0.03% | 324 |
|
|
2023
Q3 | $1.64M | Sell |
21,899
-556
| -2% | -$42.8K | 0.03% | 327 |
|
|
2023
Q2 | $1.73M | Sell |
22,455
-10,685
| -32% | -$852K | 0.03% | 317 |
|
|
2023
Q1 | $2.75M | Sell |
33,140
-959
| -3% | -$79.4K | 0.05% | 268 |
|
|
2022
Q4 | $2.93M | Sell |
34,099
-903
| -3% | -$71.5K | 0.06% | 262 |
|
|
2022
Q3 | $2.16M | Buy |
35,002
+4,996
| +17% | +$315K | 0.04% | 284 |
|
|
2022
Q2 | $1.85M | Buy |
30,006
+470
| +2% | +$29.1K | 0.04% | 278 |
|
|
2022
Q1 | $1.76M | Sell |
29,536
-332
| -1% | -$21.2K | 0.03% | 305 |
|
|
2021
Q4 | $2.17M | Buy |
29,868
+2,079
| +7% | +$143K | 0.04% | 276 |
|
|
2021
Q3 | $1.94M | Buy |
27,789
+8,102
| +41% | +$569K | 0.04% | 282 |
|
|
2021
Q2 | $1.36M | Sell |
19,687
-7,358
| -27% | -$491K | 0.03% | 293 |
|
|
2021
Q1 | $1.75M | Buy |
27,045
+16,842
| +165% | +$1.09M | 0.05% | 256 |
|
|
2020
Q4 | $595K | Sell |
10,203
-473
| -4% | -$28.5K | 0.02% | 296 |
|
|
2020
Q3 | $675K | Sell |
10,676
-125
| -1% | -$8.67K | 0.02% | 253 |
|
|
2020
Q2 | $831K | Sell |
10,801
-235
| -2% | -$18K | 0.03% | 236 |
|
|
2020
Q1 | $825K | Buy |
+11,036
| New | +$763K | 0.04% | 222 |
|
|
2019
Q3 | – | Sell |
-3,672
| Closed | -$248K | – | 356 |
|
|
2019
Q2 | $248K | Sell |
3,672
-2,008
| -35% | -$132K | 0.01% | 318 |
|
|
2019
Q1 | $370K | Sell |
5,680
-469
| -8% | -$31.2K | 0.02% | 276 |
|
|
2018
Q4 | $384K | Buy |
6,149
+257
| +4% | +$18K | 0.02% | 254 |
|
|
2018
Q3 | $455K | Sell |
5,892
-651
| -10% | -$49.2K | 0.02% | 245 |
|
|
2018
Q2 | $464K | Sell |
6,543
-2,539
| -28% | -$179K | 0.02% | 240 |
|
|
2018
Q1 | $685K | Sell |
9,082
-416
| -4% | -$33.1K | 0.04% | 204 |
|
|
2017
Q4 | $680K | Buy |
9,498
+2,897
| +44% | +$220K | 0.04% | 203 |
|
|
2017
Q3 | $535K | Sell |
6,601
-5,489
| -45% | -$420K | 0.03% | 215 |
|
|
2017
Q2 | $856K | Sell |
12,090
-228
| -2% | -$15.2K | 0.05% | 182 |
|
|
2017
Q1 | $837K | Buy |
12,318
+5,062
| +70% | +$356K | 0.05% | 177 |
|
|
2016
Q4 | $520K | Sell |
7,256
-1,014
| -12% | -$75.4K | 0.03% | 202 |
|
|
2016
Q3 | $654K | Buy |
8,270
+405
| +5% | +$32.9K | 0.04% | 186 |
|
|
2016
Q2 | $656K | Buy |
7,865
+300
| +4% | +$26.6K | 0.05% | 185 |
|
|
2016
Q1 | $695K | Sell |
7,565
-88
| -1% | -$7.94K | 0.05% | 179 |
|
|
2015
Q4 | $774K | Buy |
7,653
+979
| +15% | +$102K | 0.05% | 179 |
|
|
2015
Q3 | $655K | Buy |
6,674
+330
| +5% | +$36.7K | 0.05% | 187 |
|
|
2015
Q2 | $743K | Sell |
6,344
-1,922
| -23% | -$210K | 0.05% | 182 |
|
|
2015
Q1 | $811K | Buy |
8,266
+363
| +5% | +$36.9K | 0.06% | 180 |
|
|
2014
Q4 | $745K | Buy |
7,903
+1,808
| +30% | +$187K | 0.05% | 183 |
|
|
2014
Q3 | $649K | Buy |
6,095
+962
| +19% | +$94.2K | 0.05% | 183 |
|
|
2014
Q2 | $426K | Buy |
5,133
+150
| +3% | +$11.7K | 0.03% | 210 |
|
|
2014
Q1 | $353K | Buy |
+4,983
| New | +$391K | 0.03% | 228 |
|
Other funds holding GILD
Peapack-Gladstone Financial Corp's GILD Position: Q2 2026 in Review
Peapack-Gladstone Financial Corp increased its Gilead Sciences (GILD) stake by 9.1% in Q2 2026, buying an estimated $121K and bringing the position to 10,991 shares worth $1.39M. The position accounts for 0.02% of the portfolio, ranked #382.
Peapack-Gladstone Financial Corp first reported a position in GILD in Q1 2014 and has held it in 48 quarters since. The position peaked at $2.93M in Q4 2022. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Peapack-Gladstone Financial Corp held 10,991 shares of Gilead Sciences worth $1.39M as of Q2 2026.
- Peapack-Gladstone Financial Corp bought 917 Gilead Sciences shares in Q2 2026, an estimated $121K.
- Gilead Sciences made up 0.02% of Peapack-Gladstone Financial Corp's portfolio in Q2 2026, its #382 holding.
- Peapack-Gladstone Financial Corp first reported a position in Gilead Sciences in Q1 2014 and has held it in 48 quarters since.
- Peapack-Gladstone Financial Corp's Gilead Sciences position peaked at $2.93M in Q4 2022.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2026, filed 14 Aug 2026.